Portal vein thrombosis in patients with cirrhosis.
作者信息
Boyer Thomas D, Habib Shahid
机构信息
Department of Medicine University of Arizona, Arizona Health Sciences Center Tucson AZ.
出版信息
Clin Liver Dis (Hoboken). 2014 Jun 25;3(6):111-113. doi: 10.1002/cld.331. eCollection 2014 Jun.
Abstract
摘要
相似文献
1
Portal vein thrombosis in patients with cirrhosis.肝硬化患者的门静脉血栓形成
Clin Liver Dis (Hoboken). 2014 Jun 25;3(6):111-113. doi: 10.1002/cld.331. eCollection 2014 Jun.
2
Systematic review: portal vein thrombosis in cirrhosis.系统评价：肝硬化门静脉血栓形成。
Aliment Pharmacol Ther. 2010 Feb 1;31(3):366-74. doi: 10.1111/j.1365-2036.2009.04182.x. Epub 2009 Oct 23.
3
[Portal vein thrombosis in patients with cirrhosis].[肝硬化患者的门静脉血栓形成]
Rev Med Suisse. 2017 Aug 30;13(572):1470-1473.
4
Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients.肝硬化门静脉血栓形成的发生率。对708例患者的血管造影研究。
Gastroenterology. 1985 Aug;89(2):279-86. doi: 10.1016/0016-5085(85)90327-0.
5
Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis.肝硬化与非肝硬化患者门静脉血栓形成的诊断、发展和治疗。
Gastroenterology. 2019 May;156(6):1582-1599.e1. doi: 10.1053/j.gastro.2019.01.265. Epub 2019 Feb 13.
6
Refractory ascites due to portal vein thrombosis in liver cirrhosis--report of two cases.肝硬化门静脉血栓形成所致难治性腹水——两例报告
Hepatogastroenterology. 1998 Sep-Oct;45(23):1777-80.
7
Nonselective beta-blockers and the risk of portal vein thrombosis in patients with cirrhosis: results of a prospective longitudinal study.非选择性β受体阻滞剂与肝硬化患者门静脉血栓形成风险：一项前瞻性纵向研究的结果。
Aliment Pharmacol Ther. 2019 Mar;49(5):582-588. doi: 10.1111/apt.15137. Epub 2019 Jan 22.
8
[Treatment of nontumoral portal vein thrombosis in cirrhosis].[肝硬化非肿瘤性门静脉血栓形成的治疗]
Gastroenterol Hepatol. 2014 Jul;37 Suppl 2:62-7. doi: 10.1016/S0210-5705(14)70071-8.
9
[Portal thrombosis and liver cirrhosis. Value of ultrasound-guided puncture-biopsy of the thrombus].[门静脉血栓形成与肝硬化。超声引导下血栓穿刺活检的价值]
Gastroenterol Clin Biol. 1995 Jun-Jul;19(6-7):581-6.
10
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry.门静脉血栓形成与肝硬化的相关性：意大利静脉血栓形成事件登记处
Intern Emerg Med. 2016 Dec;11(8):1059-1066. doi: 10.1007/s11739-016-1416-8. Epub 2016 Mar 30.
引用本文的文献
1
Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.肝硬化患者非恶性门静脉血栓形成抗凝治疗的安全性、有效性及反应预测因素：一项倾向评分匹配分析
Clin Mol Hepatol. 2014 Dec;20(4):384-91. doi: 10.3350/cmh.2014.20.4.384. Epub 2014 Dec 24.
本文引用的文献
1
When and why portal vein thrombosis matters in liver transplantation: a critical audit of 174 cases.当门静脉血栓在肝移植中为何重要：174 例的关键审核。
Ann Surg. 2014 Apr;259(4):760-6. doi: 10.1097/SLA.0000000000000252.
2
Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis.肝硬化患者未治疗的门静脉血栓形成对肝移植前后结局的影响。
Ann Hepatol. 2013 Nov-Dec;12(6):952-8.
3
Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation.经颈静脉肝内门体分流术预防等待肝移植的肝硬化患者发生门静脉完全血栓形成的疗效
Transplant Proc. 2012 Nov;44(9):2603-5. doi: 10.1016/j.transproceed.2012.09.050.
4
Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis.肝硬化患者肝外非恶性部分门静脉血栓形成的自然病程。
Radiology. 2012 Oct;265(1):124-32. doi: 10.1148/radiol.12112236. Epub 2012 Aug 13.
5
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis.依诺肝素可预防晚期肝硬化患者门静脉血栓形成和肝功能失代偿。
Gastroenterology. 2012 Nov;143(5):1253-1260.e4. doi: 10.1053/j.gastro.2012.07.018. Epub 2012 Jul 20.
6
Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: a systematic review.肝硬化患者门静脉血栓形成的抗凝管理：一项系统评价
Int J Hepatol. 2012;2012:672986. doi: 10.1155/2012/672986. Epub 2012 Jun 20.
7
Portal vein thrombosis, cirrhosis, and liver transplantation.门静脉血栓形成、肝硬化和肝移植。
J Hepatol. 2012 Jul;57(1):203-12. doi: 10.1016/j.jhep.2011.12.034. Epub 2012 Mar 21.
8
Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.前瞻性评估抗凝和经颈静脉肝内门体分流术治疗肝硬化门静脉血栓形成。
Liver Int. 2012 Jul;32(6):919-27. doi: 10.1111/j.1478-3231.2012.02785.x. Epub 2012 Mar 21.
9
Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.抗凝治疗肝硬化并门静脉血栓形成患者的疗效和安全性。
Clin Gastroenterol Hepatol. 2012 Jul;10(7):776-83. doi: 10.1016/j.cgh.2012.01.012. Epub 2012 Jan 28.
10
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.经颈静脉肝内门体分流术治疗肝硬化合并门静脉血栓形成并出现症状性门静脉高压。
J Hepatol. 2011 Jan;54(1):78-88. doi: 10.1016/j.jhep.2010.06.029. Epub 2010 Aug 27.
Zotero 插件